Brainstorm Cell Therapeutics shares owned by Caldwell Sutter Capital
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Caldwell Sutter Capital
from 13F filings
Historical chart of Caldwell Sutter Capital investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Caldwell Sutter Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Brainstorm Cell Therapeutics by Caldwell Sutter Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $0 | 157k | 0.00 |